MORN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Buy now for a tactical rebound setup: MORN is extremely oversold (RSI-6 11) and sitting right on first support (179.6), which often precedes short, sharp mean-reversion moves.", "Positioning/sentiment supports a bounce: hedge funds meaningfully increased buying last quarter (+395.58%), and options open interest is heavily call-skewed (bullish tilt).", "Near-term catalyst is close: earnings (QDec 2025) on 2026-02-12 after hours\u2014this can accelerate a rebound if results stabilize margins/EPS, but also keeps the tape reactive until then.", "Intellectia Proprietary Trading Signals\n- AI Stock Picker: No signal on given stock today.\n- SwingMax: No signal on given stock today."]
["Trend is bearish: moving averages are stacked bearishly (SMA_200 > SMA_20 > SMA_5), indicating the broader downtrend is still intact.", "Momentum is negative and deteriorating: MACD histogram is -3.472 and negatively expanding (selling pressure still building).", "Extremely oversold condition: RSI_6 at 11.088 suggests capitulation/flush dynamics and raises the probability of a short-term snapback.", "Key levels: Support S1 ~179.559 (price 180.18 is just above); next support S2 ~169.89 if S1 fails. Overhead pivot/resistance ~195.209, then R1 ~210.86.", "Pattern-based forward odds provided: +1.24% next day, +1.23% next week, -0.53% next month\u2014consistent with a short-term bounce inside a weaker medium-term structure."]
increases odds of a near-term mean-reversion bounce.", "Hedge funds are buying aggressively (+395.58% QoQ buying amount), a supportive demand signal.", "Berkeley increased exposure (17,382 shares; ~$3.78M in Q4 2025), reinforcing institutional confidence despite the drawdown.", "Upcoming earnings (2026-02-12 after hours) can re-rate the stock quickly if guidance/earnings stabilize."]
["Primary trend remains down (bearish MA stack) and MACD is worsening\u2014bounce risk of failing and rolling over remains high.", "Event risk: earnings are imminent, and the options market is pricing high uncertainty (IV percentile ~98).", "Support is nearby but fragile: a clean break below ~179.6 exposes ~169.9 as the next downside magnet.", "Company\u2019s most recent reported quarter showed profitability pressure (YoY net income and EPS down materially)."]
["Latest quarter provided: 2025/Q3.", "Revenue: $617.4M, up +8.43% YoY (steady top-line growth).", "Profitability weakened: Net income $91.6M, down -23.48% YoY.", "EPS: 2.17, down -21.66% YoY (earnings compression despite revenue growth).", "Gross margin: 53.24%, up +0.72% YoY (slight margin improvement at the gross level, but not enough to prevent net income/EPS decline)."]
["No analyst rating or price target change data was provided in the dataset, so a recent trend summary cannot be confirmed from the supplied inputs.", "Wall Street-style pros (from available signals): consistent revenue growth, modest gross margin improvement, strong hedge-fund accumulation, and supportive call-skew in options positioning.", "Wall Street-style cons (from available signals): recent EPS/net income contraction and a clearly bearish technical trend into a major catalyst (earnings), implying the market is still debating the earnings trajectory."]
